SlideShare a Scribd company logo
1 of 24
MANAGEMENT OF DIABETIC
KETOACIDOSIS
KEERTHIKA.V
1 ST YEAR
PERIODONTICS AND IMPLANTOLOGY
CONTENTS
 Introduction
 Causes
 Pathophysiology
 Symptoms
 Diagnosis
 Management
DIABETIC KETOACIDOSIS
 Diabetic ketoacidosis is an acute, major, life-threatening complication of
diabetes.DKA mainly occurs in patient with type I diabetes, but it is also not
uncommon in some patients with type 2diabetes.
 Also it can be the very initial presentation of the previously undiagnosed pt with
type 1 diabetic mellitus.
 This condition is a complex disordered metabolic state characterized by
hyperglycemia, ketoacidosis, and ketouria.
CAUSES OF DKA
TYPE I DIABETIC MELLITUS
 In 25% of patients, DKA is present at
diagnosis of type 1 diabetes due to
acute insulin deficiency.
 Poor compliance with insulin.
 Bacterial infection and recurrent
illness[eg,urinary tract infection[UTI],
vomiting]
 Medical,surgical, or emotional stress.
 Idiopathic
TYPE II DIABETIC
MELLITUS
 Intercurrent illness [eg.myocardial
infarction,pneumonia,prostatitis,UTI].
 Medication[eg,corticosteroids,pentami
dine,clozapine.]
 Diabetic ketoacidosis[DKA] usually evolves rapidly, over 24-hr period.
 The earliest symptoms of marked hyperglycemia are polyuria, polydipsia, and
weight loss
 Dehydration
 Acidotic [Kussmaul’s]breathing, with a fruity smell[acetone].
 Abdominal pain or distension.
 Vomiting.
 An altered mental status ranging from disorientation to coma.
 Blood pressure and pulse.
 Temperature.
TO DIAGNOSE DKA ,THE FOLLOWING CRITERIA MUST BE FULFILLED.
The American Diabetes association diagnostic criteria for DKA are as follow:
 Elevated serum glucose level
 An elevated serum ketone level.
 A PH less than 7.3 and
 A serum bicarbonate level less than 18 mEq per L
MANAGEMENT
PRINCIPLES OF MANAGEMENT OF DIABETIC
KETOACIDOSIS
 Rapid correction of dehydration.
 Rapidly acting regular insulin,early and enough.
 Correction of acidosis.
 Treatment of precipitating cause, if found.
 Correction of hypokalemia and hypophosphatemia.
 Nursing management.
 Measure capillary glucose every 1-2 h and electrolytes every 4h for 24h.
DKA
INSULIN
BICARBONATES
INFUSION
ELECTROLYTES FLUIDS
FLUID
REPLACEMENT
FLUID REPLACEMENT
 Determine hydration status:
Hypovolemic shock
Administer 0.9% saline, Ringer’s lactate or a plasma expander as a bolus dose of
15-20 ml/kg. This can be repeated if the state of shock persists.
 Dehydration without shock ;
1. Adminster 0.9% Saline4-14 ml/kg/hr for an initial hr, to restore blood volume and
renal perfusion.
2. If serum sodium is high or normal start with 0.45% saline.
When serum glucose reaches 250mg/dl change fluid to 5% dextrose with 0.45% saline,at a
rate that allow complete restoration in 48 hrs, and to maintain glucose at 150-250
mg/dl.
INSULIN THERAPY
 Start regular insulin 0.5 unit/kg as IV Bolus.
 Start infusing regular insulin at a rate of 0.1%/kg/hr using a syringe pump.Optimally,
serum glucose should decrease in a rate no faster than 100mg/dl/hr.
 If serum glucose falls <200 prior to correction of acidosis, change IV fluid from D5 to
D10, but don’t decrease the rate of insulin infusion.
CORRECTION OF ELECTROLYTE IMBALANCE
 Regardless of K conc.at presentation,total body K is low.So, as soon as the
urine output is restored potassium supplementation must be added to Iv fluid at
a conc. Of 20-40 mmol/l, where 50% of it given as KCL, and the rest as
potassium phosphate, this will provide phosphate for repalcement, and avoids
excess phosphate[may precipitate hypocalcaemia].
POTASSIUM AND PHOSPHATE
 If k conc.<3.3mEq/l,administer 40mEq/l of KCL in IV saline over 1
hr.Withhold insulin until K conc.becomes >3.3mEq/l and moniter K
conc.hourly.
 If serum potassium is 5 or more,do not give potassium recheck in every2 hrs.
 If initial potassium is > 3.3 but < 5mEq/l give 20-30mEq/l of K in each liter in
each liter of Iv fluids[2/3 as KCL and 1/3 as KPO4 to keep K to 4-5mEq/l].
BICARBONATE
 If ph<6.9
Bicarbonate [100 osmol] dilute in 400 ml of H2O.infused at 200 ml/h.
 If ph <6.9-7.0
Bicarbonate [50 osmol] dilute in 200ml of H2O.
Infused at 200ml/h
 If ph >7
No bicarbonate.
MONITORING
 A flow chart must be used to moniter fluid balance and lab measures.
 Serum glucose must be measured hourly.
 Electrolyte also 2-3 hourly.
 Ca,Mg,and phosphate must be measured initially and atleast once during
therapy.
 Neurological and mental state must examined frequently and any complaints of
headache or deterioration of mental status should prompt rapid evaluation for
possible cerebral edema.
…

More Related Content

What's hot

What's hot (20)

Junctional epithelium
Junctional epitheliumJunctional epithelium
Junctional epithelium
 
Periodontal pathogenesis
Periodontal pathogenesisPeriodontal pathogenesis
Periodontal pathogenesis
 
Advanced Glycation Endproducts and diabetes
Advanced Glycation Endproducts and diabetes Advanced Glycation Endproducts and diabetes
Advanced Glycation Endproducts and diabetes
 
Inflammation and Immunity in periodontitis ppt
Inflammation and Immunity in periodontitis pptInflammation and Immunity in periodontitis ppt
Inflammation and Immunity in periodontitis ppt
 
Alveolar bone in health and disease
Alveolar bone in health and disease Alveolar bone in health and disease
Alveolar bone in health and disease
 
Role of diet and nutrition in periodontal health
Role of diet and nutrition in  periodontal healthRole of diet and nutrition in  periodontal health
Role of diet and nutrition in periodontal health
 
Microbiology of periodontal disease- part 2
Microbiology of periodontal disease- part 2Microbiology of periodontal disease- part 2
Microbiology of periodontal disease- part 2
 
Saliva
SalivaSaliva
Saliva
 
Microbiology of periodontal diseases
Microbiology of periodontal diseasesMicrobiology of periodontal diseases
Microbiology of periodontal diseases
 
The role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progressionThe role of NSAIDs in periodontal disease progression
The role of NSAIDs in periodontal disease progression
 
Peridontium and sex hormones
Peridontium  and sex hormonesPeridontium  and sex hormones
Peridontium and sex hormones
 
Role of hormones in periodontal health and disease
Role of hormones in periodontal health and diseaseRole of hormones in periodontal health and disease
Role of hormones in periodontal health and disease
 
Cytokines in Periodontal Diseaase
Cytokines in Periodontal DiseaaseCytokines in Periodontal Diseaase
Cytokines in Periodontal Diseaase
 
JUNCTIONAL EPITHELIUM IN HEALTH & DISEASE-- REGENERATION FOLLOWING SURGERY
JUNCTIONAL EPITHELIUM IN HEALTH & DISEASE-- REGENERATION FOLLOWING SURGERYJUNCTIONAL EPITHELIUM IN HEALTH & DISEASE-- REGENERATION FOLLOWING SURGERY
JUNCTIONAL EPITHELIUM IN HEALTH & DISEASE-- REGENERATION FOLLOWING SURGERY
 
Dento gingival unit
Dento gingival unitDento gingival unit
Dento gingival unit
 
stress and periodontium
stress and periodontiumstress and periodontium
stress and periodontium
 
NSAIDs in Periodontology
NSAIDs in PeriodontologyNSAIDs in Periodontology
NSAIDs in Periodontology
 
Regulation of blood sugar
Regulation of blood sugarRegulation of blood sugar
Regulation of blood sugar
 
Gingival keratinization ppt
Gingival keratinization pptGingival keratinization ppt
Gingival keratinization ppt
 
Periodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic healthPeriodontal Medicine: Impact of periodontal disease on systemic health
Periodontal Medicine: Impact of periodontal disease on systemic health
 

Similar to DIABETIC MELLITUS -MANAGEMENT OF DIABETIC KETOACIDOSIS 'PHARM'.pptx

DKA diabetes ketoacidosis in children.ppt
DKA diabetes ketoacidosis in children.pptDKA diabetes ketoacidosis in children.ppt
DKA diabetes ketoacidosis in children.ppt
ssuser69abc5
 
diabetesketoacidosis about education pdf
diabetesketoacidosis about education pdfdiabetesketoacidosis about education pdf
diabetesketoacidosis about education pdf
Akash782029
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dm
siifan23
 

Similar to DIABETIC MELLITUS -MANAGEMENT OF DIABETIC KETOACIDOSIS 'PHARM'.pptx (20)

DIABETIC KETOACIDOSIS (DKA)
DIABETIC KETOACIDOSIS (DKA)DIABETIC KETOACIDOSIS (DKA)
DIABETIC KETOACIDOSIS (DKA)
 
Diabetic Ketoacidosis Management Protocol _Internal Medicine KHC
Diabetic Ketoacidosis Management Protocol _Internal Medicine KHCDiabetic Ketoacidosis Management Protocol _Internal Medicine KHC
Diabetic Ketoacidosis Management Protocol _Internal Medicine KHC
 
DIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSISDIABETIC KETO ACIDOSIS
DIABETIC KETO ACIDOSIS
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
 
DKA diabetes ketoacidosis in children.ppt
DKA diabetes ketoacidosis in children.pptDKA diabetes ketoacidosis in children.ppt
DKA diabetes ketoacidosis in children.ppt
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
diabetesketoacidosis about education pdf
diabetesketoacidosis about education pdfdiabetesketoacidosis about education pdf
diabetesketoacidosis about education pdf
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosis
 
DKA clinical teach.pptx specially for nursing students
DKA clinical teach.pptx specially for nursing studentsDKA clinical teach.pptx specially for nursing students
DKA clinical teach.pptx specially for nursing students
 
Dibetic Ketoacidosis in Children
Dibetic Ketoacidosis in ChildrenDibetic Ketoacidosis in Children
Dibetic Ketoacidosis in Children
 
DKA.pptx
DKA.pptxDKA.pptx
DKA.pptx
 
Diabetic ketoacidosis.pptx
Diabetic ketoacidosis.pptxDiabetic ketoacidosis.pptx
Diabetic ketoacidosis.pptx
 
Acute complications of Diabetes Mellitus
Acute complications of Diabetes MellitusAcute complications of Diabetes Mellitus
Acute complications of Diabetes Mellitus
 
Diabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptxDiabetic Ketoacidosis Management Guideline.pptx
Diabetic Ketoacidosis Management Guideline.pptx
 
Diabetic emergencies.pdf
Diabetic emergencies.pdfDiabetic emergencies.pdf
Diabetic emergencies.pdf
 
Dka mgt
Dka mgtDka mgt
Dka mgt
 
Dka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copyDka pathphysiology & management 2014 - copy
Dka pathphysiology & management 2014 - copy
 
Diabetic ketoacidosis
Diabetic ketoacidosisDiabetic ketoacidosis
Diabetic ketoacidosis
 
Diabetes ketoacidosis
Diabetes ketoacidosisDiabetes ketoacidosis
Diabetes ketoacidosis
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dm
 

Recently uploaded

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Recently uploaded (20)

Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 

DIABETIC MELLITUS -MANAGEMENT OF DIABETIC KETOACIDOSIS 'PHARM'.pptx

  • 1. MANAGEMENT OF DIABETIC KETOACIDOSIS KEERTHIKA.V 1 ST YEAR PERIODONTICS AND IMPLANTOLOGY
  • 2. CONTENTS  Introduction  Causes  Pathophysiology  Symptoms  Diagnosis  Management
  • 3. DIABETIC KETOACIDOSIS  Diabetic ketoacidosis is an acute, major, life-threatening complication of diabetes.DKA mainly occurs in patient with type I diabetes, but it is also not uncommon in some patients with type 2diabetes.  Also it can be the very initial presentation of the previously undiagnosed pt with type 1 diabetic mellitus.  This condition is a complex disordered metabolic state characterized by hyperglycemia, ketoacidosis, and ketouria.
  • 4. CAUSES OF DKA TYPE I DIABETIC MELLITUS  In 25% of patients, DKA is present at diagnosis of type 1 diabetes due to acute insulin deficiency.  Poor compliance with insulin.  Bacterial infection and recurrent illness[eg,urinary tract infection[UTI], vomiting]  Medical,surgical, or emotional stress.  Idiopathic TYPE II DIABETIC MELLITUS  Intercurrent illness [eg.myocardial infarction,pneumonia,prostatitis,UTI].  Medication[eg,corticosteroids,pentami dine,clozapine.]
  • 5.
  • 6.
  • 7.
  • 8.  Diabetic ketoacidosis[DKA] usually evolves rapidly, over 24-hr period.  The earliest symptoms of marked hyperglycemia are polyuria, polydipsia, and weight loss
  • 9.  Dehydration  Acidotic [Kussmaul’s]breathing, with a fruity smell[acetone].  Abdominal pain or distension.  Vomiting.  An altered mental status ranging from disorientation to coma.  Blood pressure and pulse.  Temperature.
  • 10. TO DIAGNOSE DKA ,THE FOLLOWING CRITERIA MUST BE FULFILLED. The American Diabetes association diagnostic criteria for DKA are as follow:  Elevated serum glucose level  An elevated serum ketone level.  A PH less than 7.3 and  A serum bicarbonate level less than 18 mEq per L
  • 11.
  • 12. MANAGEMENT PRINCIPLES OF MANAGEMENT OF DIABETIC KETOACIDOSIS  Rapid correction of dehydration.  Rapidly acting regular insulin,early and enough.  Correction of acidosis.  Treatment of precipitating cause, if found.  Correction of hypokalemia and hypophosphatemia.  Nursing management.  Measure capillary glucose every 1-2 h and electrolytes every 4h for 24h.
  • 15. FLUID REPLACEMENT  Determine hydration status: Hypovolemic shock Administer 0.9% saline, Ringer’s lactate or a plasma expander as a bolus dose of 15-20 ml/kg. This can be repeated if the state of shock persists.
  • 16.  Dehydration without shock ; 1. Adminster 0.9% Saline4-14 ml/kg/hr for an initial hr, to restore blood volume and renal perfusion. 2. If serum sodium is high or normal start with 0.45% saline. When serum glucose reaches 250mg/dl change fluid to 5% dextrose with 0.45% saline,at a rate that allow complete restoration in 48 hrs, and to maintain glucose at 150-250 mg/dl.
  • 18.  Start regular insulin 0.5 unit/kg as IV Bolus.  Start infusing regular insulin at a rate of 0.1%/kg/hr using a syringe pump.Optimally, serum glucose should decrease in a rate no faster than 100mg/dl/hr.  If serum glucose falls <200 prior to correction of acidosis, change IV fluid from D5 to D10, but don’t decrease the rate of insulin infusion.
  • 19. CORRECTION OF ELECTROLYTE IMBALANCE  Regardless of K conc.at presentation,total body K is low.So, as soon as the urine output is restored potassium supplementation must be added to Iv fluid at a conc. Of 20-40 mmol/l, where 50% of it given as KCL, and the rest as potassium phosphate, this will provide phosphate for repalcement, and avoids excess phosphate[may precipitate hypocalcaemia].
  • 20. POTASSIUM AND PHOSPHATE  If k conc.<3.3mEq/l,administer 40mEq/l of KCL in IV saline over 1 hr.Withhold insulin until K conc.becomes >3.3mEq/l and moniter K conc.hourly.  If serum potassium is 5 or more,do not give potassium recheck in every2 hrs.  If initial potassium is > 3.3 but < 5mEq/l give 20-30mEq/l of K in each liter in each liter of Iv fluids[2/3 as KCL and 1/3 as KPO4 to keep K to 4-5mEq/l].
  • 21. BICARBONATE  If ph<6.9 Bicarbonate [100 osmol] dilute in 400 ml of H2O.infused at 200 ml/h.  If ph <6.9-7.0 Bicarbonate [50 osmol] dilute in 200ml of H2O. Infused at 200ml/h  If ph >7 No bicarbonate.
  • 22. MONITORING  A flow chart must be used to moniter fluid balance and lab measures.  Serum glucose must be measured hourly.  Electrolyte also 2-3 hourly.  Ca,Mg,and phosphate must be measured initially and atleast once during therapy.  Neurological and mental state must examined frequently and any complaints of headache or deterioration of mental status should prompt rapid evaluation for possible cerebral edema.
  • 23.
  • 24.